We present the clinical case of a 38 year old woman diagnosed with rheumatoid arthritis at the age of 32. She went into remission of her disease during treatment with subcutaneous methotrexate (25 mg/week) for 2 years. She decided to become pregnant and stoped treatment. RA relapses 4 months later and she has no response to classic DMARD's (sulphassalazine and hydroxychloroquine) and starts etanercept (50mg/week). She gets pregnant and achieves remission at week 16 of her pregnancy. At week 36 she is still in remission and stops etanercept. 2 months after giving birth the disease relapses but she wants to breastfeed and would like to restart etanercept. We agreed and 3 months after restarting anti-TNF RA is again in remission. In January 2017 her RA is inremission for 15 months and keeps her medication with etanercept every other week because she plans another pregnancy.
Disclosure of Interest None declared